×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

2110 Total Publications

Higher rates of decline for women and apolipoprotein E epsilon4 carriers.
Holland, D., Desikan, R. S., Dale, a M., & McEvoy, L. K.
2013; Journal American Journal of Neuroradiology; vol. 34; no. 12; pp. 2287-93; doi:10.3174/ajnr.A3601
Critical ages in the life course of the adult brain: nonlinear subcortical aging.
Fjell, A. M., Westlye, L. T., Grydeland, H., Amlien, I., Espeseth, T., Reinvang, I., … Walhovd, K. B.
2013; Journal Neurobiology of Aging; vol. 34; no. 10; pp. 2239-47; doi:10.1016/j.neurobiolaging.2013.04.006
Prevalence of Alzheimer’s pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
Lampert, E. J., Roy Choudhury, K., Hostage, C. a, Petrella, J. R., & Doraiswamy, P. M.
2013; Journal PloS One; vol. 8; no. 4; pp. e60747; doi:10.1371/journal.pone.0060747
Latent feature representation with stacked auto-encoder for AD/MCI diagnosis.
Suk, H.-I., Lee, S.-W., & Shen, D.
2013; Journal Brain Structure and Function; pp. 1-19; doi:10.1007/s00429-013-0687-3
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman, V. a., Carmichael, O. T., Schwarz, C., Tosto, G., Zimmerman, M. E., & Brickman, A. M.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 5; pp. S124-S131; doi:10.1016/j.jalz.2012.11.009
Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment.
Westman, E., Aguilar, C., Muehlboeck, J.-S., & Simmons, A.
2013; Journal Brain Topography; vol. 26; no. 1; pp. 9-23; doi:10.1007/s10548-012-0246-x
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; doi:10.1007/s00406-013-0405-4
Dynamics of brain structure and cognitive function in the Alzheimer’s disease neuroimaging initiative.
Song, X., Mitnitski, A., Zhang, N., Chen, W., & Rockwood, K.
2013; Journal Journal of Neurology, Neurosurgery, and Psychiatry; vol. 84; no. 1; pp. 71-8; doi:10.1136/jnnp-2012-303579
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
Landau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M., Mathis, C. a, Jagust, W. J., & Mintun, M. a.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 1; pp. 70-7; doi:10.2967/jnumed.112.109009